Patents by Inventor Christopher S. Wilcox

Christopher S. Wilcox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130023560
    Abstract: Methods and compositions for the treatment of iron toxicity using nitroxides, particularly 4-hydroxy-2,2,6,6-tetramethyl-1-piperidine-1-oxyl (Tempol), N-acetylcysteine (NAC), and combinations thereof.
    Type: Application
    Filed: March 20, 2012
    Publication date: January 24, 2013
    Applicant: Georgetown University
    Inventors: Christopher S. Wilcox, Pouneh Nouri
  • Publication number: 20110130421
    Abstract: Methods and compositions for the treating chronic renal hypertension in a subject comprising administering a therapeutically effective amount of at least one nitroxide-containing composition to the subject, particularly 4-hydroxy-2,2,6,6-tetramethyl-1-piperidine-1-oxyl (Tempol).
    Type: Application
    Filed: October 28, 2010
    Publication date: June 2, 2011
    Applicant: Georgetown University
    Inventors: Christopher S. Wilcox, William J. Welch, Fredrik Palm
  • Publication number: 20100081689
    Abstract: Methods and compositions for the treatment of iron toxicity using nitroxides, particularly 4-hydroxy-2,2,6,6-tetramethyl-1-piperidine-1-oxyl (Tempol), N-acetylcysteine (NAC), and combinations thereof.
    Type: Application
    Filed: September 24, 2009
    Publication date: April 1, 2010
    Applicant: Georgetown University
    Inventors: Christopher S. Wilcox, Pouneh Nouri
  • Patent number: 6617337
    Abstract: The present invention encompasses methods of treating patients for essential hypertension. The invention also includes related pharmaceutical compositions of nitroxides. Specific drugs, such as 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy (Tempol) are disclosed. These compositions are also contemplated for use in the treatment of oxidative stress and modulation of blood pressure.
    Type: Grant
    Filed: January 5, 2001
    Date of Patent: September 9, 2003
    Assignee: Georgetown University
    Inventor: Christopher S. Wilcox
  • Patent number: 6096759
    Abstract: This invention relates to the treatment of essential hypertension by administration of anti-hypertensive effective amounts of 4-hydroxy-2,2,6,6-tetramethyl-1-piperidine-1-oxyl (tempol).
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: August 1, 2000
    Assignee: Georgetown University
    Inventor: Christopher S. Wilcox